M. Gardner

发表

Single and multiple dose pharmacokinetics of tenidap sodium in healthy subjects.

K. Wilner, M. Gardner, R. Hansen, 1995, British journal of clinical pharmacology.

Enhanced biotransformation of theophylline in marihuana and tobacco smokers

Jerome J. Schentag, W. Jusko, M. Gardner, 1978, Clinical pharmacology and therapeutics.

Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

J J Schentag, W J Jusko, J W Vance, 1979, Journal of pharmaceutical sciences.

A Single‐Dose Pharmacokinetic Study of Lasofoxifene in Healthy Volunteers and Subjects With Mild and Moderate Hepatic Impairment

D. Ouellet, M. Gardner, E. Randinitis, 2006, Journal of clinical pharmacology.

Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene.

D. Ouellet, M. Gardner, E. Randinitis, 2007, British journal of clinical pharmacology.

Effect of fluconazole on the disposition of phenytoin

Jerome J. Schentag, M. Gardner, J. Wilton, 1991, Clinical pharmacology and therapeutics.

Effect of Sertraline on the Pharmacokinetics and Protein Binding of Diazepam in Healthy Volunteers

S. Preskorn, K. Wilner, M. Gardner, 1997, Clinical pharmacokinetics.

Pharmacokinetics of fluconazole in renal failure.

T. Berl, K. Wilner, M. Gardner, 1995, Journal of the American Society of Nephrology : JASN.

Clinical Pharmacology of Lasofoxifene in Japanese and White Postmenopausal Women

M. Gardner, R. Fountaine, L. Dogolo, 2006, Journal of clinical pharmacology.

Effects of oral contraceptives and tobacco use on the metabolic pathways of theophylline

W. Jusko, M. Gardner, 1986 .

Clinical Pharmacology of Multiple Doses of Lasofoxifene in Postmenopausal Women

M. Gardner, A. Milton, B. Duncan, 2006, Journal of clinical pharmacology.

Longitudinal effects of pregnancy on the pharmacokinetics of theophylline

W. Jusko, M. Schatz, E. Middleton, 2004, European Journal of Clinical Pharmacology.

Reduction in dissociation due to aging and cognitive deficit.

M. Gardner, R. Bloch, R. Walker, 1996, Comprehensive psychiatry.

Cimetidine-methylprednisolone-theophylline metabolic interaction.

W. Jusko, W. Ebling, M. Gardner, 1984, The American journal of medicine.

Effects of lasofoxifene on the pharmacokinetics and pharmacodynamics of single-dose warfarin.

D. Ouellet, M. Gardner, E. Randinitis, 2006, British journal of clinical pharmacology.

Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension

M. Gardner, H. Fouda, M. Nahata, 1993, Antimicrobial Agents and Chemotherapy.

Increased gastric pH and the bioavailability of fluconazole and ketoconazole.

Jerome J. Schentag, M. Gardner, J. Wilton, 1991, Annals of Internal Medicine.

Relationship of serum thiocyanate concentrations to smoking characteristics.

W. Jusko, M. Gardner, T. L. McCarthy, 1984, Journal of toxicology and environmental health.

Induction of Fluconazole Metabolism by Rifampin: In Vivo Study in Humans

M. Gardner, G. Apseloff, N. Gerber, 1991, Journal of clinical pharmacology.

INTERACTION BETWEEN CYCLOSPORINE AND FLUCONAZOLE IN RENAL ALLOGRAFT RECIPIENTS

B. Carleton, A. Matas, M. Gardner, 1991, Transplantation.

Effects of tobacco smoking and oral contraceptive use on theophylline disposition.

W. Jusko, M. Gardner, K. Tornatore, 1983, British journal of clinical pharmacology.

Effect of chronic oral contraceptive steroids on theophylline disposition

W. Jusko, M. Gardner, A. Yurchak, 2004, European Journal of Clinical Pharmacology.

Pharmacokinetics of single and multiple doses of ethinyl estradiol and levonorgestrel in relation to smoking

W. Jusko, M. Gardner, K. Tornatore, 1988, Clinical pharmacology and therapeutics.

Effect of age and sex on theophylline clearance in young subjects.

W. Jusko, M. Gardner, 1982, Pediatric pharmacology.

Cimetidine does not alter the clearance or plasma binding of tenidap in healthy male volunteers.

M. Gardner, K. Wilner, 1995, British journal of clinical pharmacology.

Evaluation of the effect of lasofoxifene (LASO) on the pharmacokinetics (PK) of digoxin

D. Ouellet, M. Gardner, C. Bramson, 2005 .

The effects of age and gender on the pharmacokinetics of tenidap sodium in patients with rheumatoid arthritis and osteoarthritis.

R. Hansen, M. Gardner, J. Caldwell, 1995, British journal of clinical pharmacology.

Tenidap sodium does not alter the clearance or plasma protein binding of tolbutamide in healthy male volunteers.

M. Gardner, K. Wilner, MJ Gardner, 1995, British journal of clinical pharmacology.

The effect of tenidap sodium on the disposition and plasma protein binding of phenytoin in healthy male volunteers.

Jerome J. Schentag, M. Gardner, R. Blum, 1995, British journal of clinical pharmacology.

Disposition of Lasofoxifene, a Next-Generation Selective Estrogen Receptor Modulator, in Healthy Male Subjects

C. Prakash, M. Gardner, Kim A. Johnson, 2008, Drug Metabolism and Disposition.

Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children.

M. Rapport, M. Gardner, G. DuPaul, 1994, Journal of the American Academy of Child and Adolescent Psychiatry.

Theophylline disposition in residents living near a chemical waste site.

W. Jusko, M. Gardner, B. Paigen, 1984, Biopharmaceutics & drug disposition.

Attention Deficit Disorder and Methylphenidate: Group and Single-Subject Analyses of Dose Effects on Attention in Clinic and Classroom Settings

M. Rapport, M. Gardner, G. DuPaul, 1987 .

Effects of Steady-State Lasofoxifene on Cyp2D6- and Cyp2E1-Mediated Metabolism

R. Obach, R. Walsky, M. Gardner, 2006, The Annals of pharmacotherapy.

Effect of Lasofoxifene on the Pharmacokinetics of Digoxin in Healthy Postmenopausal Women

D. Ouellet, M. Gardner, E. Randinitis, 2005, Journal of clinical pharmacology.